This study, published in the New England Journal of Medicine, assessed the feasibility of integrating the RTS,S/AS02D malaria vaccine into a standard expanded program on immunization (EPI) schedule for infants. The study, conducted in Tanzania, showed that the use of the RTS,S/AS02D vaccine in infants had a promising safety profile, did not interfere with the immunologic responses to coadministered EPI antigens, and reduced the incidence of malaria infection.

Author(s): Abdulla S, Oberholzer R, Juma O, et al.

Published: 2008

Resource types: Peer-reviewed journal

Diseases: Malaria

Topics: Vaccine safety; Disease/vaccine specific information

Regions: Africa